Related Experiment Video
Updated: Jul 20, 2026

Assessment of Plasma Coagulation on Liver Tissue in a Large Animal Model In Vivo
Published on: August 4, 2018
Coagulation disorders secondary to acute liver failure in Amanita phalloides poisoning: a case report
Dilek Soysal1, Cetin Cevik, Aras Saklamaz
1Department of Internal Medicine, Atatürk Research Hospital, Izmir, Turkey. dileksoysal@hotmail.com
Abstract:
Amanita mushroom poisoning is a serious occurrence. Physicians need to recognize the syndrome promptly and institute effective treatment as soon as possible in order to avoid the often fatal complications. We report a case of a young man with mushroom poisoning of the genus Amanita with a clinical spectrum that ranged from hepatic failure and coagulation disorders to an outcome with a partial recovery. The aim of this report was to emphasize the clinical outcomes and treatment regimens in this type of mushroom poisoning seen with increasing frequency in our region.
Insights
Amanita mushroom poisoning can cause severe liver damage and bleeding issues. Prompt medical treatment is crucial for patient survival and recovery from this potentially fatal condition.
Area of Science:
- Toxicology
- Mycology
- Internal Medicine
Background:
- Amanita mushroom poisoning represents a significant medical emergency.
- Early recognition and intervention are vital to prevent severe complications.
Observation:
- A case of a young male patient with Amanita mushroom poisoning is presented.
- The patient exhibited a range of symptoms including hepatic failure and coagulation disorders.
Findings:
- The clinical course demonstrated a spectrum from severe organ dysfunction to partial recovery.
- Effective treatment regimens were explored in the context of this poisoning.
Implications:
- This case highlights the importance of timely diagnosis and management of Amanita mushroom poisoning.
- Increased frequency of such poisonings in the region necessitates heightened awareness and preparedness.
More Related Videos
Related Concept Videos
Anticholinesterase Agents: Poisoning and Treatment
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
Hepatic Encephalopathy
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Prevention of Further Absorption of Poison
Physical Properties of Amines
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

